Viewing Study NCT00830518


Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2026-01-26 @ 3:47 PM
Study NCT ID: NCT00830518
Status: COMPLETED
Last Update Posted: 2018-05-11
First Post: 2009-01-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myelogenous Leukemia View
None High-Grade Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Drug therapy View